Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rosemary extract shows promise for diabetes health markers in early trial

NCT ID NCT07541729

First seen Apr 23, 2026 · Last updated May 24, 2026 · Updated 4 times

Summary

This early-phase study tests whether rosemary extract can improve markers of oxidative stress and inflammation in 40 adults with type 2 diabetes. Participants take either rosemary extract or a placebo for 12 weeks. The goal is to see if this natural supplement can support metabolic health, but it is not a cure and requires ongoing diabetes management.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado)

    Zacatecas City, Zacatecas, 98160, Mexico

Conditions

Explore the condition pages connected to this study.